John D. Rice

A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.

S. Gadgeel, G. Kalemkerian, N. Ramnath, 2023, Clinical lung cancer.